Northwire Canada EditionSaturday, November 7, 2026
Northwire
⌕
Gold 4,079.60 −0.8% Silver 51.94 −0.8% Copper 6.24 −0.5% Oil 90.83 +0.3% Palladium 1,017.10 −2.6% KRN 0.260 −7.1% GSKR 2.84 +5.6% ADE 0.125 +4.2% NRM 0.055 +0.0% BBB 0.520 −1.9% LGD 2.09 +1.9% DEC 0.110 +0.0% LCE 0.200 +0.0% NILI 0.515 −1.0% CDE 21.85 +6.7% CAN 0.045 +0.0% LORD 0.100 +0.0% HBM 29.49 +2.3% ELEF 0.265 +120.8% MUN 0.300 +0.0% SAGA 0.400 +6.7% Gold 4,079.60 −0.8% Silver 51.94 −0.8% Copper 6.24 −0.5% Oil 90.83 +0.3% Palladium 1,017.10 −2.6% KRN 0.260 −7.1% GSKR 2.84 +5.6% ADE 0.125 +4.2% NRM 0.055 +0.0% BBB 0.520 −1.9% LGD 2.09 +1.9% DEC 0.110 +0.0% LCE 0.200 +0.0% NILI 0.515 −1.0% CDE 21.85 +6.7% CAN 0.045 +0.0% LORD 0.100 +0.0% HBM 29.49 +2.3% ELEF 0.265 +120.8% MUN 0.300 +0.0% SAGA 0.400 +6.7%
Financings

Psyence Group Inc. Provides Update on Proposed Amalgamation with GoldCoast Resource Corp.

PSYG · Price

Executive Summary

  • GoldCoast Resource Corp. closed the first brokered private placement, issuing 6,853,840 common shares at $0.85 per share for gross proceeds of $5,825,764.
  • Proceeds are earmarked to fund GoldCoast’s exploration activities and working capital, and satisfy a condition precedent to the proposed amalgamation with Psyence Group Inc.
  • The financing enables the company to pursue additional non‑brokered tranches in the coming weeks, advancing the pending reverse‑takeover transaction.

Key Details

  • Shares Issued: 6,853,840 GoldCoast common shares.
  • Price per Share: $0.85.
  • Gross Proceeds: $5,825,764.
  • Use of Proceeds: Exploration activities and working capital for GoldCoast; satisfies a condition precedent to the Psyence‑GoldCoast amalgamation.
  • Financing Structure: First tranche of a brokered private placement; additional non‑brokered tranches expected at the same price in upcoming weeks.
  • Amalgamation Context: Completion of this financing is required under the Amalgamation Agreement dated November 21, 2025 (amended February 24, 2026). The transaction remains subject to shareholder and regulatory approvals and CSE requirements.
  • Forward‑Looking Statements: Include expectations for further tranches, use of proceeds, and successful completion of the amalgamation; subject to risks and uncertainties outlined in Psyence’s MD&A.

Notable Quotes

(No direct quotes were provided in the release.)

Read the original news release →

More from Psyence Group Inc.